Valuation

Valuation is the estimated worth of a company at a specific moment, calculated through multiple methods. Methods include comparables analysis (looking at recent transactions of similar companies), discounted cash flow (modeling future cash flows back to present value), market-based pricing (what the marginal investor will pay), asset-based methods (for asset-heavy businesses), and for early-stage startups, venture-style heuristics anchored on round dynamics, growth-stage benchmarks, and qualitative assessments of team, market, and momentum. It is the number that shapes every fundraising conversation, every employee equity grant, every acquisition discussion, and every founder anxiety about whether they're being underpriced or overpaying themselves.

The methods, by use case:

• Comparables / "comps" analysis: most-used method for venture-stage companies. Find recent fundings or acquisitions of similar-stage, similar-sector companies; apply their valuation multiples (revenue, ARR, EBITDA, sometimes users) to your metrics. Strong because it reflects actual market behavior; weak because the comps are often imperfect matches.
• Discounted cash flow (DCF): model 5-10 years of projected cash flows, discount to present value at a risk-adjusted rate. Theoretically rigorous; practically unreliable for early-stage startups where projections are deeply uncertain. Most useful for mature businesses with predictable cash flows.
• Venture method: popularized by Bill Sahlman at HBS. Estimate the company's exit value, work backward through expected dilution to figure out post-money at each round needed to deliver the investor's target return.
• Berkus method: for very-early-stage companies, assigns dollar values to qualitative factors (sound idea, prototype, quality team, strategic relationships, product rollout). Caps at roughly $2-2.5M pre-money. Mostly historical curiosity now.
• Scorecard method: Bill Payne's framework for angel-stage valuation, scoring the company against regional pre-money benchmarks across team, opportunity, product, sales, competitive environment, etc.
• Market-based / "what they'll pay": the practical method for most venture rounds. Test investor appetite, get term sheets, see what the market actually clears at.

The venture-stage benchmarks override all of the textbook methods. Typical 2024-2025 ranges (Carta data): pre-seed $5-15M post-money, seed $10-30M, Series A $30-80M, Series B $80-250M, Series C $200M-1B+. Within those ranges, growth rate, ARR, team quality, market timing, and competitive dynamics determine the specific point. The 409A valuation is a separate concept, an IRS-required appraisal for option grants, deliberately lower than the most-recent preferred-round valuation. Acquisition and IPO valuations use exit-multiple methods anchored on ARR multiples (4-15x for SaaS at scale), EBITDA multiples (8-15x for profitable mature businesses), or industry-specific frameworks.

What founders get wrong: Optimizing the headline valuation at the expense of cleaner terms. Higher valuations often come with worse terms (participating preferred, ratchets, multiple-X preferences) that change the math at exit dramatically. A modest valuation with clean 1x non-participating preferred typically beats an inflated valuation with structural protections that erode founder upside. Model the waterfall under realistic exit scenarios before celebrating the valuation.

Related: Pre-Money Post-Money Valuation · 409A Valuation · Exit Multiple · Venture Capital · Cap Table

FAQ

What is valuation?
The estimated worth of a company at a specific moment, calculated through methods including comparables analysis, discounted cash flow, market-based pricing, asset-based methods, and venture-style heuristics. The number that anchors fundraising, equity grants, acquisitions, and most strategic financial decisions.

What are typical startup valuations by stage?
2024-2025 Carta benchmarks: pre-seed $5-15M post-money, seed $10-30M, Series A $30-80M, Series B $80-250M, Series C $200M-1B+. Within those ranges, growth rate, ARR, team quality, market timing, and competitive dynamics determine the specific point.

Which valuation method should I use?
For early-stage venture: comparables analysis + market-based pricing (test investor appetite, get term sheets). For mature profitable businesses: DCF or EBITDA multiples. For very-early-stage angel: scorecard or qualitative venture-method heuristics. 409A valuations for option grants use a separate IRS-required appraisal method, deliberately lower than the most-recent preferred-round valuation.